Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer

Figure 4

The immune-related signature can be predictive of survival of gastric cancer patients with different clinicopathological features. Kaplan-Meier curves of OS between the high- and low-risk groups for patients with (a) and (b) ; (c) female and (d) male; (e) G1-2 and (f) G3; (g) T1-2 and (h) T3-4; (i) N0 and (j) N1-3; (k) M0 and (l) M1; (m) stage I-II and (n) stage III-IV.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)